Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Newsroom  arrow down
    < Back
    • Press Releases
    • Media Statements
    • Media Library
    • Contacts

    • Subscribe
    • Our 2023 Integrated Annual Report is live!

      Featured Image
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Accounts
    • Investor Events
    • Financial Calendar
    • Corporate News
    • Regulated Information
    • Shareholder Information
    • Contacts
    • Subscribe
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Locations
    • Adverse Event Reporting
    • Subscribe
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Health
      < Back
    • Health
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
    • R&D
    • Pipeline
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
    • Partnering
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories

Post navigation

Previous
Next

Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer

Information relating to the compensation elements of Mr. David LOEW, Chief Executive Officer

- 09 February 2023 - 0 mins read

Post navigation

Previous
Next
Related Documents
  • Information-relating-to-the-compensation-elements-of-D.-Loew   Download  (124 KB)

Related Reports and Accounts

Information relating to compensation elements of Mr. David Loew, CEO – 31 May 2023
02 June 2023 0 mins read

Information relating to compensation elements of Mr. David Loew, CEO – 31 May 2023

Compensation policy for corporate officers Combined shareholders’ meeting of 31 May 2023
01 June 2023 0 mins read

Compensation policy for corporate officers Combined shareholders’ meeting of 31 May 2023

2022 Integrated Annual Report
31 May 2023 1 mins read

2022 Integrated Annual Report

2022 Universal Registration Document
06 April 2023 1 mins read

2022 Universal Registration Document

2021 Integrated Annual Report
31 May 2022 0 mins read

2021 Integrated Annual Report

Information relating to compensation elements
25 May 2022 0 mins read

Information relating to compensation elements

Compensation policy for corporate officers, result of vote SM
25 May 2022 0 mins read

Compensation policy for corporate officers, result of vote SM

2021 Universal Registration Document
14 April 2022 0 mins read

2021 Universal Registration Document

Information relating to compensation elements
28 May 2021 0 mins read

Information relating to compensation elements

Compensation policy for corporate officers, result of vote SM
28 May 2021 0 mins read

Compensation policy for corporate officers, result of vote SM

IPN price

€104.80

 €1.60 (1.55%)

  • Media Library
  • Adverse Event Reporting
  • Annual Report
  • Locations
  • Contacts

Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Contacts
  • Terms & Conditions
  • Cookie Policy
  • Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2024

You are now leaving the Ipsen group website.
To continue, please click on Continue?

Continue
♿
Increase the text(+) Decrease the text(-) Reset
Screen Reader
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.